Related Experiment Video
Updated: Jul 14, 2026
08:41
Functional Characterization of Regulatory Macrophages That Inhibit Graft-reactive Immunity
Published on: June 7, 2017
Scavenger receptor-A negatively regulates antitumor immunity
Xiang-Yang Wang1, John Facciponte, Xing Chen
1Department of Cellular Stress Biology, Roswell Park Cancer Institute, Buffalo, New York 14263, USA. xiang-yang.wang@roswellpark.org
Cancer Research
|May 19, 2007
Summary
Scavenger receptor-A (SR-A) negatively regulates antitumor immunity. Removing SR-A enhances heat shock protein (HSP) vaccine efficacy by boosting T-cell responses and improving dendritic cell function.
Area of Science:
- Immunology
- Cancer Research
- Vaccinology
Background:
- Scavenger receptor-A (SR-A) is known for lipoprotein uptake and roles in innate immunity and pathogen infection.
- SR-A acts as a receptor for heat shock proteins (HSPs) on antigen-presenting cells, influencing antigen cross-presentation.
- Its role in adaptive antitumor immunity, particularly with HSP-based vaccines, was previously unclear.
Purpose of the Study:
- To investigate the role of SR-A in antitumor immunity generated by HSP-based vaccine approaches.
- To determine if SR-A influences the efficacy of vaccine adjuvants like HSPs and lipopolysaccharide.
- To elucidate the impact of SR-A deficiency on immune cell function and antigen presentation in the context of cancer immunotherapy.
Main Methods:
- Utilized SR-A knockout (KO) mice and wild-type (WT) littermates.
- Administered HSP-based vaccines and lipopolysaccharide (LPS) to assess antitumor responses.
- Analyzed antigen-specific T-cell responses and dendritic cell (DC) function, including responsiveness to inflammatory stimuli and antigen-presenting capabilities.
Main Results:
- SR-A is not essential for antitumor immunity mediated by HSP-based vaccines.
- Lack of SR-A significantly enhanced the efficacy of HSP- or LPS-mediated vaccination against poorly immunogenic tumors.
- SR-A deficiency led to increased antigen-specific T-cell responses and improved DC function, including enhanced responsiveness to inflammatory stimuli.
- SR-A was identified as a negative regulator of antigen-specific antitumor immunity.
Conclusions:
- SR-A negatively regulates antigen-specific antitumor immunity.
- SR-A deficiency enhances the efficacy of HSP- and LPS-mediated vaccine strategies.
- These findings have significant clinical implications for designing cancer immunotherapies and optimizing vaccine strategies by targeting SR-A.
- SR-A-deficient DCs exhibit superior antigen-presenting capabilities, suggesting a potential therapeutic target.
Related Concept Videos
01:15Receptor Downregulation in MVBs
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:12Role Of Notch Signalling In Intestinal Stem Cell Renewal
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
01:40Cell-mediated Immune Responses
Overview
01:28Diversity of Antigen Receptors
Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...